Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Hepatitis C in Hemophilic Patients With HIV
This study has been completed.
Study NCT00055341 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: February 25, 2003 Last Updated: July 29, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Hepatitis C
Hemophilia
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Hemophilia A
Hepatitis
Infection
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders
Digestive System Diseases
Flaviviridae Infections
Genetic Diseases, Inborn
Hematologic Diseases
Hemorrhagic Disorders
Hepatitis, Viral, Human
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Liver Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Peginterferon alfa-2a
Ribavirin
Additional drug interventions recognized in this trial
Interferon Alfa-2a
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antimetabolites
Antineoplastic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
